Michael Cookson, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myovant Sciences
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas Pharma, Inc.
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    TesoRx Pharma LLC
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myovant Sciences
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas Pharma, Inc.
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    TesoRx Pharma LLC
    Date added:
    Date updated:
    11/05/2024
Return to The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion (2021)